Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5-11 years with persistent asthma: A randomized trial

This multi‐center, randomized, double‐blind, placebo‐controlled, two‐way crossover study characterized the safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate (FF) in children (5–11 years) with persistent asthma. Twenty‐seven children received inhaled FF 100 µg or pla...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical pharmacology in drug development 2014-03, Vol.3 (2), p.144-150
Hauptverfasser:	Oliver, Amanda, Allen, Ann, VanBuren, Sandi, Hamilton, Melanie, Tombs, Lee, Kempsford, Rodger, Qaqundah, Paul
Format:	Artikel
Sprache:	eng
Schlagworte:	Asthma children fluticasone furoate pharmacokinetics and pharmacodynamics Placebo effect tolerability
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!